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Seasonal epidemics of influenza A virus are a major cause
of severe illness and are of high socio-economic rele-
vance. For the design of effective antiviral therapies, a
detailed knowledge of pathways perturbed by virus infec-
tion is critical. We performed comprehensive expression
and organellar proteomics experiments to study the cel-
lular consequences of influenza A virus infection using
three human epithelial cell lines derived from human lung
carcinomas: A549, Calu-1 and NCI-H1299. As a common
response, the type I interferon pathway was up-regulated
upon infection. Interestingly, influenza A virus infection
led to numerous cell line-specific responses affecting
both protein abundance as well as subcellular localiza-
tion. In A549 cells, the vesicular compartment appeared
expanded after virus infection. The composition of au-
tophagsomes was altered by targeting of ribosomes, viral
mRNA and proteins to these double membrane vesicles.
Thus, autophagy may support viral protein translation by
promoting the clustering of the respective molecular
machinery in autophagosomes in a cell line-dependent
manner. Molecular & Cellular Proteomics 17: 10.1074/
mcp.RA117.000364, 1909–1921, 2018.
Influenza virus infections of the human respiratory tract are
a major cause of morbidity and mortality (1). Annual epidem-
ics mainly affect young, elderly, or chronically ill people and
are estimated to result in up to 5 million cases of severe
illness, including up to 650,000 fatal outcomes worldwide (1).
Seasonal epidemics occur because of accumulation of mu-
tations in the viral surface protein hemagglutinin (antigenic
drift), which interfere with the activation of a humoral immune
response (2). Antigenic shift, which is the process of combi-
nation of different virus strains leading to new subtypes (3),
may result in the rarely occurring influenza A virus (IAV)1
pandemics, such as the “Spanish Flu” in 1918–1919, which
gave rise to tens of millions of deaths worldwide (4).
Because of the high mutation rates of viral RNA, therapies
based on antiviral drugs targeting virally encoded proteins
themselves have likely only limited effects (5). A powerful
alternative to interfere with viral replication is the targeting of
critical host factors. Hence, several genome-wide RNAi
screens were performed to identify host factors necessary for
IAV replication (6–8). In parallel, global MS-based proteomics
studies were performed to identify such factors. These anal-
yses focused either on the identification and characterization
of host-virus protein interactions (9, 10), or on the analyses of
IAV-induced changes in host protein abundances (11–13). In
the current study, we aimed to characterize comprehensively
IAV-induced changes in the host cell proteome and to study
the influence of different cell lines on the observed effects.
As IAV modifies and hijacks numerous processes and cell
organelles during its replication cycle (14), we also aimed to
characterize the dynamic, IAV-induced regulation of the sub-
cellular localization of protein complexes. After endocytic cell
entry, viral ribonucleoprotein complexes (vRNPs) are released
into the cytoplasm and enter the nucleus where viral mRNA
synthesis and replication occurs (15, 16). A cell process uti-
lized by IAV that recently attracted attention is autophagy, a
catabolic recycling process that targets organelles and mul-
tiprotein complexes for lysosomal degradation (17). Critically,
the phenotypic consequences of IAV-autophagy crosstalk are
still under debate. It was shown in several studies that IAV
blocks the maturation of autophagosomes (18), which are
double membrane vesicles that shuttle intracellular cargo to
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lysosomes. The autophagic membranes are further redirected
to the plasma membrane to enable the release of viral parti-
cles with increased stability (19). In contrast, induction of
functional autophagy by IAV was also reported (20, 21).
Here, we present expression proteomics and organellar
proteomics data, highlighting the multifaceted influences of
IAV on human proteome composition and distribution of host
protein complexes. Depending on the used cell line, different
perturbed pathways were observable indicating that conflict-
ing publications might be the result of the employed model
systems. We emphasize common as well as cell line-specific
signaling pathways and new molecular players regulated by
IAV infection. Specifically, we study the impact of IAV on the
vesicular proteome, i.e. autophagosomes, discussing a po-
tential new role of these organelles in viral protein translation.
EXPERIMENTAL PROCEDURES
Cells and Culture Conditions—Adherent human A549, Calu-1 and
NCI-H1299 cells were cultured and passaged in high glucose DMEM
(PAA Laboratories GmbH, Coelbe, Germany), supplemented with
10% FBS, 1% Penicillin/Streptomycin, and 1% L-glutamine. For
SILAC-labeling, cells were grown in SILAC-DMEM (high glucose)
(Thermo-Fisher Scientific, Langenselbold, Germany), supplemented
with 10% dialyzed FBS (Invitrogen, Darmstadt, Germany), 1% Peni-
cillin/Streptomycin, and 1% L-glutamine, containing a final concen-
tration of 42 mg/l L-arginine HCl (Arg0), 73 mg/l L-lysine HCl (Lys0)
and 1.33 mg/l L-proline for light labeling (Sigma-Aldrich, Taufen-
kirchen, Germany). Arg0 and Lys0 were replaced by L-arginine-
13C6
14N4 and L-lysine-
2H4 (Arg6, Lys4) for medium-heavy, or L-argi-
nine-13C6-
15N4 and L-lysine-
13C6
15N2 (Arg10, Lys8) for heavy labeled
cells (Silantes, Mu¨nchen, Germany). To gain full incorporation of
labeled amino acids, cells were cultured for at least 5 cell doublings in
the corresponding label. For harvesting, cells were washed 3 times with
ice cold DPBS, collected with a cell scraper, centrifuged at 1000 g for
5 min and cell pellets were stored at 80 °C for further use.
Experimental Design and Statistical Rationale—We minimally ana-
lyzed two biological replicates from all conditions. Correlations of
respective data are shown in the supplemental information. Values of
biological replicates were combined as average and log2 transformed
to generate normal distributions. All statistical tests were corrected
for multiple testing as outlined in the respective paragraphs.
IAV Infection—Cells (60–70% confluence) were washed twice
with RPMI (PAA Laboratories) and incubated with influenza virus
strain X:31 A/AICHI/68 (Charles River, Wilmington, MA; Batch:
4XAP091028) in RPMI at a multiplicity of infection (MOI) of 2 PFU per
cell (for IF staining a MOI of 4 was used) for 1 h at 37 °C with 5% CO2.
Cells were washed once with DPBS and incubated with complete
DMEM (high glucose) for 24 h.
Cell Fractionation—Cell pellets were taken up in homogenization
medium (HM; 0.25 M Sucrose, 1 mM EDTA, 20 mM HEPES-NaOH pH
7.4), containing protease inhibitor (Complete protease inhibitor mix-
ture, Roche Diagnostics GmbH, Mannheim, Germany). The solution
was dounced 150 times followed by several centrifugation steps to
collect nuclear (1000  g), mitochondrial (3000  g) and vesicular
fractions (17,000  g). The supernatant of the last centrifugation was
collected as the cytosolic fraction. All pellets were dissolved in HM
and centrifuged for a second time at the respective speed to reduce
copurifying contaminants.
The mitochondrial and vesicular fractions were dissolved in mod-
ified RIPA buffer (1% NP-40, 150 mM NaCl, 50 mM Tris pH 7.5, 0.25%
Na-deoxycholate) and incubated on ice for 10 min followed by a
centrifugation for 10 min at 17,000  g at 4 °C.
The nuclear pellet was taken up in 3 ml of S1 (0.25 M Sucrose, 10
mM MgCl2). This solution was layered over 3 ml of S2 (0.35 M Sucrose,
0.5 mM MgCl2), and centrifuged at 1430  g for 5 min at 4 °C. The
pellet was again taken up in 3 ml S1 and the procedure was repeated.
The nuclear pellet was taken up in modified RIPA buffer and the nuclei
were opened by sonification (3  30 s with 50% intensity in an
ultrasonic bath, kept at ice in between), followed by a centrifugation at
3000  g for 10 min at 4 °C. The supernatant was used as nucleo-
plasmic fraction. The protein amount of all collected fractions was
determined (BCA Protein Assay kit, PierceR, Thermo-Fisher scientific)
according to the manufacturer‘s protocol, adjusted and the fractions
were further processed for MS or Western blotting.
Autophagosome Purification by Protein Correlation Profiling—Cell
pellets were treated as outlined above. The 17,000  g pellet con-
taining the vesicular fraction was dissolved in 1 ml HM and loaded on
top of an iodixanol gradient (Sigma Aldrich). The gradient was made
of five 1.6 ml gradient steps (5, 10, 16, 24, and 30% iodixanol in HM),
prepared by underlying layers with higher density solutions in 12 ml
centrifugation tubes. Vesicles were separated on the gradient for 17 h
at 100,000  g at 6 °C in a swing out rotor. Fractions of 1 ml were
collected, diluted with 1 ml HM and centrifuged at 4 °C for 20 min at
40,000  g in a fixed angle rotor. Pellets were taken up in 25 l
SDS-PAGE loading buffer and further processed for MS or Western
blotting (22).
Protease Protection Assay—The vesicular fraction gained by dif-
ferential centrifugation was used to perform the protease protection
assay. Vesicular pellets were dissolved in HM and split into 5 tubes.
One sample was left untreated, two were treated with 40 g/ml and
80 g/ml proteinase K, respectively, and two were treated with 0.2%
triton and 40 g/ml and 80 g/ml proteinase K, respectively. Samples
were vortexed and incubated for 30 min on ice. 7% TFA was used to
stop protease activity. The precipitated proteins were pelleted via
centrifugation for 10 min at 4 °C at 21,100 g and washed twice with
acetone. 1 x SDS-loading buffer containing 1 mM DTT was added and
the samples were brought into solution by heating them to 75 °C for
30 min.
Western Blotting—Samples were mixed with SDS-PAGE loading
buffer with 1 mM DTT and incubated for 10 min at 95 °C. Samples
were separated by SDS-PAGE on self-casted SDS-gels (dependent
on protein size, gels between 7.5% and 12.5% were used) and
transferred onto nitrocellulose membranes. Membranes were blocked
with 5% milk powder in 1 TBS with 0.1% Tween-20 for 1 h at room
temperature and incubated for 1 h at RT or ON at 4 °C with primary
antibodies. HRP-coupled secondary antibodies and a chemilumines-
cent detection assay were used for visualization according to manu-
facturer‘s instructions.
Following primary antibodies were used in a 1:1000 dilution based
on reactivity against single specific bands of the correct molecular
weight: Santa Cruz Biotechnology, Inc., Heidelberg, Germany: Anti-
beta-actin (sc-47778), Anti-DTX3L (sc-100627), Anti-EEA1 (G-4, sc-
137130), Anti-GFP (B-2, sc-9996), Anti-Influenza A NS1 (NS1–23-1,
sc-130568), Anti-PARP14 (sc-377150), Anti-Ribosomal Protein L4
1 The abbreviations used are: IAV, influenza A virus; ABC, ammo-
nium bicarbonate; AP, affinity purification; BH, Benjamini-Hochberg;
conA, concanamycin A; FDR, false discovery rate; GFP, green fluo-
rescent protein; IF, immunofluorescence; LC, liquid chromatography;
MOI, multiplicity of infection; ON, over night; PAMP, pathogen-asso-
ciated molecular pattern; PCP, protein correlation profiling; PFU,
plaque-forming unit; RT, room temperature; SEC, size exclusion chro-
matography; SILAC, stable isotope labelling by amino acids in cell
culture; vRNPs, viral ribonucleoprotein complexes; WB, Western blot;
WCL, whole cell lysate.
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(RQ-7, sc-100838), Anti-Tom20 (F-10, sc-17764), Anti-UBC8 (sc-
135629). Abcam, Cambridge, United Kingdom: Anti-beta-tubulin
(ab6046), Anti-MCM7 (47DC141). Roche: Anti-HA (11867423001).
Cell Signaling Technology, Inc., Danvers, MA: Anti-Lamin A/C (2032),
Anti-LC3 A/B (4108). Biomol: Anti-p62/SQSTM1 (PW 986). Merck,
Darmstadt, Germany: Anti-GAPDH (MAB374).
Following secondary antibodies were used. Thermo-Fisher Scien-
tific: Alexa fluor 488 (A21042), Alexa fluor 488 (A21206), Alexa fluor
568 (A11011), Alexa fluor 568 (A10037). GE Healthcare, Mu¨nchen,
Germany: Anti-rabbit HRP (NA934V), Anti-mouse HRP (NXA931). Di-
anova GmbH, Hamburg, Germany: Anti-rat HRP (112-035-062).
Autophagic Flux Assays—Protein intensities detected by Western
blotting were quantified by densitometry and analyzed using imageJ
analysis software. The level of LC3-II was normalized to GAPDH as
loading control. Autophagic flux was calculated as intensity of LC3-II
with conA divided by intensity of LC3-II without conA. LC3-II in conA
treated infected cells (conAIAV) was compared with the level in
infected cells (IAV). The same was done for conA-only treated cells
compared with untreated control cells. The level of conA/untreated
was set to 100% and the (conAIAV)/IAV was adjusted accordingly.
Immunofluorescence Staining—For indirect IF staining, A549 cells
were grown on coverslips, fixed with 4% PFA and blocked with 1%
BSA in PBS for 30 min at RT. Incubation with primary antibodies
diluted in 1% BSA in PBS was performed for 1 h at RT or ON at 4 °C.
After incubation with the fluorophore-coupled secondary antibody in
1% BSA in PBS for 1 h, the samples were embedded in fluorescence
mounting medium, containing DAPI. Pictures were taken with an IF
microscope.
RNA Purification, cDNA Synthesis and PCR Conditions—For RNA
purification, cell pellets or pellets of the vesicular fraction after gradi-
ent centrifugation were extracted with the RNeasy Mini kit following
the manufacturer‘s instructions using the RLT buffer. Dependent on
the experiments, 1 g of total RNA was reverse transcribed using the
First Strand cDNA Synthesis Kit with random hexamer primers. PCR
primer: M1, ATGAGTCTTCTAACCGAGG, TCACTTGAACCGTTG-
CATC ; NS1, ATGGATCCAAACACTGTGTC, TCAAACTTCTGACCTA-
ATTGTT.
MS Sample Preparation—Samples were lysed in SDS-PAGE load-
ing buffer, reduced with 1 mM DTT for 10 min at 95 °C and alkylated
using 5.5 mM iodoacetamide for 30 min at 25 °C in the dark. Proteins
were separated by SDS-PAGE using 4–12% Bis-Tris gels (NuPAGE,
Thermo Fisher). Staining with Colloidal Blue was used to visualize
proteins. Gel lanes were cut into 10 slices of equal size, which were
cut into small cubes. Remaining Colloidal Blue was washed out by
incubation with ABC buffer (100 mM ammonium bicarbonate pH 7.5)
for 10 min followed by incubation for 10 min in ethanol. This was
repeated three times. Gel pieces were dried and 50 l of 12.5 ng/l
trypsin (MS grade, Promega, Mannheim, Germany) were added. After
gel swelling additional 50 l of ABC buffer were added. Samples were
proteolytically digested ON at 37 °C. Trypsin activity was stopped by
acidification with 50 l 0.5% TFA. Remaining peptides were washed
out of the gel cubes by two incubations in 100 l ethanol. Superna-
tants containing peptides of the respective slice were combined and
peptide solutions were concentrated to less than 50 l in a speedvac.
Samples were desalted on STAGE tips as described (23).
Mass Spectrometry—Samples were fractionated by HPLC on ei-
ther a 1200 (Agilent Technologies; Waldbronn, Germany) or a NanoLC
Ultra (Eksigent, AB SCIEX, Redwood City, CA) connected online to a
LTQ Orbitrap XL mass spectrometer, or an EasyLC 1000 nanoflow-
HPLC connected online to a QExactive Plus mass spectrometer
(Thermo Fisher Scientific, Bremen, Germany). Fused silica HPLC-
column tips with 75 m inner diameter were self-packed with Repro-
sil-Pur 120 ODS-3 (Dr. Maisch, Ammerbuch, Germany) to a length of
20 cm. Samples were directly injected into the mass spectrometer
and peptides were separated using a gradient of A (0.5% acetic acid
in MS-grade water, Thermo Fisher) and B (0.5% acetic acid in 80%
acetonitrile in water, both MS-grade, Thermo Fisher). Sample loading
was performed with 2% B with a flow rate of 500 nl/min. For sepa-
ration a linear gradient from 10–30% B within 85 min with a flow rate
of 250 nl/min was applied. The spray voltage was set to 2.3 kV and
the ion-transfer tube had a temperature of 125 °C. Mass spectrome-
ters were operated in the data-dependent mode. For LTQ Orbitrap XL
analyses, all full-scans were recorded in the Orbitrap in the range from
m/z 370 to 2,000 and at resolution 60,000. MS/MS scans were
recorded in the linear ion trap and the top5 method was applied. The
normalized collision energy was set to 35% at a target value of 5000.
For QExactive Plus analyses: after each MS scan (mass range m/z 
370–1750; resolution: 70,000) a maximum of ten MS/MS scans were
performed using a normalized collision energy of 25%, a target value
of 1000 and a resolution of 17,500. Singly charged and ions with
unassigned charge states were excluded from MS/MS.
Identification of Proteins and Protein Ratio Assignment Using Max-
Quant—The MS raw data files were uploaded into the MaxQuant
software (version 1.3.0.5, 1.4.1.2) (24). Database searches were per-
formed against a human database compiled with PSPad version 4.5.2
and based on UniProt human March 2018 containing IAV protein
sequences (21,021 entries in total) as well as common contaminants
such as keratins and enzymes used for in-gel digestion (262 entries in
total, supplemental Table S1). Carbamidomethylcysteine was set as
fixed modification, oxidation of methionine and protein N-terminal
acetylation were set as variable modifications. Dependent on the
experiment, double or triple SILAC was used as quantitation mode.
The enzyme specificity was trypsin/P (DP) with three allowed
missed cleavages. The MS/MS tolerance was set to 0.5 Da for ion
trap and 20 ppm for FTMS spectra and the mass precision of iden-
tified peptides after recalibration was in general less than 1 ppm. For
identification and quantitation, the following settings were used: pep-
tide and protein FDR were set to 0.01 (based on a decoy forward-
reverse database search), minimum peptide length was set to 7,
minimum number peptides for identification and quantitation of pro-
teins was set to two of which one must be unique, minimum ratio
count was set to two, and only unmodified peptides and peptides
modified by methionine oxidation and protein N-terminal acetylation
were used for protein quantification. The “match between run” option
was used with a time window of 2 min.
Data Analysis—For clustering of data, all proteins with ratios in all
six gradient fractions or in all four compartments were used to gen-
erate respective distribution profiles by applying the fuzzy c-means
clustering (26) using R 2.8.1 or GProX (27). To address the biological
implications of the proteins in each cluster, Biological Process and
Molecular Function GO terms were retrieved using Perseus (28). A
Fisher’s exact test was performed to identify enriched GO terms in the
corresponding cluster, compared with the background of all clusters.
A BH corrected FDR below 0.01, an enrichment factor of two and a
membership of at least five entries per GO term per cluster were
required to regard the enrichment as significant. Additionally, all pro-
teins of a cluster were tested for known and predicted interactions
using STRING DB (29). Cytoscape was used for visualization and
network analysis (30).
RESULTS
IAV Induces Cell Line-specific and Common Changes in the
Compositions of Host Proteomes—To determine the effects
of IAV infection on the composition of host cell proteomes, we
chose a quantitative expression proteomics approach based
on SILAC labeling analyzing both, whole cell lysate (WCL) and
major organelle fractions (Fig. 1A). Briefly, A549, Calu-1 and
Autophagosomal Targeting of Ribosomal Proteins by IAV
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FIG. 1. IAV-induced changes of host cell proteomes. A, A549, Calu-1 and NCI-H1299 epithelial cells derived from human lung carcinomas
were SILAC labeled, IAV infected for 24 h with a MOI of 2 or left untreated. Cells were either lysed (whole cell lysate (WCL)) or fractionated into
cytosol, mitochondria, nuclei and vesicles. Lysates and fractions were mixed in a ratio of 1:1, respectively, and samples were prepared for MS
analysis as outlined. Experiments were performed in two (Calu-1, H1299) and three (A549) biological replicates, respectively. B, Proteome
coverage of the three analyzed cell lines. 67% of proteins were quantified in all three cell lines, 84% in two out of three. C, Ratios of two
biological replicates of WCL analyses were averaged and used to highlight IAV-regulated proteins. Gray dots represent unaffected proteins.
Red dots represent proteins that significantly changed abundance upon IAV treatment (significance A, p  0.05, BH corrected). IAV proteins
are marked by a blue frame. D, Proteins exhibiting significant changes upon IAV infection. Protein numbers that were consistently identified
as significantly changed after IAV infection in minimum two biological replicates (significance A, p 0.05, BH corrected). 36% of proteins were
identified as significantly regulated in minimum two of the three analyzed cell lines. E, STRING interaction network of proteins significantly
changed upon IAV infection in minimum two cell lines (medium confidence 0.4). Yellow marked proteins were significantly up-regulated upon
IAV infection, blue marked proteins were significantly downregulated. Proteins marked by a red frame carry the GO BP term “response to virus”
(FDR 5.52e-05), proteins marked by a dark blue frame carry the term “type I interferon signaling pathway” (FDR 0.0194). F, A549 cells were
either left untreated or infected with IAV for 24 h with a MOI of 2. Samples were analyzed by WB with indicated antibodies. Actin served as
loading control. G, Immunofluorescence staining of untreated and IAV-infected A549 cells (MOI  4) for DTX3L and UBE2L6 (green),
respectively, and DAPI (blue). Scale bars represent 10 m.
Autophagosomal Targeting of Ribosomal Proteins by IAV
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NCI-H1299 epithelial cells derived from human lung carcino-
mas were differentially SILAC labeled and either left untreated
as control or infected for 24 h with IAV strain X:31 (A/AICHI/68)
with an MOI of 2. WCL, nuclear, mitochondrial, vesicular and
cytosolic cell fractions were mixed 1:1, respectively, and an-
alyzed as outlined (Fig. 1A, supplemental Fig. S1). In seven
biological replicates (A549, n  3; Calu-1, n  2; NCI-H1299,
n  2; supplemental Fig. S2 and S3; average Pearson corre-
lation coefficient r  0.58, spread 0.40 - 0.78), we identified
6726 proteins, of which we could quantify 6258 by minimally
two peptides (Fig. 1B, supplemental Table S2). 66.7% of all
proteins were quantified in all three cell lines, 84.3% in mini-
mally two. Fold changes comparing IAV infected versus un-
treated control cells were used to identify significantly regu-
lated host cell proteins upon IAV infection (Fig. 1C). In total,
we identified 313 proteins, which exhibited a significantly
changed abundance after IAV infection in minimum two bio-
logical replicates (Fig. 1D, Significance A, p  0.05, BH cor-
rected; supplemental Table S3). Out of these 313 candidates,
10 proteins were shown to interact with IAV proteins and to be
critical for viral replication (9). Additionally, 19 proteins were
also identified as being regulated by IAV in two other recent
MS-based proteomics studies (11, 12) (see supplemental Ta-
ble S4 for hits commonly identified by other studies). Inter-
estingly, whereas the majority of proteins was quantified in
minimally two cell lines, only 36.1% of proteins were identified
as significantly regulated in minimum two out of the three
analyzed cell lines. Thus, it appears that the response to IAV
infection is highly cell line dependent. For example, interferon-
induced proteins with tetratricopeptide repeats 1, 2, 3 and 5
(IFIT1, 2, 3, 5) were identified exclusively in A549 cells as
significantly enriched after IAV infection (supplemental Table
S3), IFIT1 being known to act as a sensor for viral single-
stranded RNA (31). Integrins 1, 3, 5, and 6 were specif-
ically increased in infected NCI-H1299, and mitochondrial
cytochrome C oxidase subunits (COX5A, COX7A2L1) in in-
fected Calu-1 cells (supplemental Table S3).
Out of the 113 proteins that were significantly changed
upon IAV infection in minimum two cell lines 37 formed an
interaction network based on STRING DB indicating a func-
tional connection between regulated proteins after infection
(Fig. 1E) (29). Among others, interacting proteins were signif-
icantly enriched in proteins of the “immune effector process”
(GO BP, FDR  0.0114) and the “type I interferon signaling
pathway” (GO BP, FDR  0.0223), such as IFN-induced
IFITM3 and STAT1 (see supplemental Tables S5 for complete
list of significant enriched GO BP, MF, and CC).
In A549 cells, we validated IAV-dependent increased abun-
dance of three proteins, which were so far not known to be
regulated by IAV. The poly [ADP-ribose] polymerase tran-
scription factor PARP14, which was described to be impor-
tant for T cell differentiation into Th2, Th17 and Tfh cells (32,
33), was shown by Western blotting (WB) to be more abun-
dant after virus infection (Fig. 1F). Next to PARP14, which was
also up-regulated in NCI-H1299 cells, we identified PARP9,
10 and 12 as exclusively up-regulated in A549 cells indicating
a broader and potentially cell line-specific effect of IAV infec-
tion on this family of transcription factors (supplemental Table
S2). The increased abundance of the E3 ubiquitin ligase
DTX3L involved in DNA damage responses was validated by
immuno-fluorescence analysis (IF) (Fig. 1G) (34). Finally, the
E2 ubiquitin-conjugating enzyme UBE2L6 was reproducibly
identified as slightly upregulated by WB and IF (Fig. 1F–1G).
UBE2L6 is the E2 enzyme of ISG15, which is known to be
involved in the anti-IAV host response (35). Interestingly, also
HERC5, the respective E3 enzyme, was identified as signifi-
cantly enriched (Fig. 1E; supplemental Table S2). Taken to-
gether, IAV infection induced a potent, cell line-specific, host
response affecting known (36) as well as new pathways po-
tentially critical in antiviral host cell signaling.
IAV Induces Changes in Subcellular Localization of Host
Proteins—In a comprehensive study addressing human cyto-
megalovirus, it was shown that viral proteins change the
subcellular localization of numerous host cell proteins (37). To
study the influence of IAV on subcellular protein localization,
we performed experiments based on a PCP-SILAC setup (38).
Briefly, in triple labeling experiments, we fractionated IAV-
infected and untreated A549, Calu-1 and NCI-H1299 cells into
vesicular, nuclear, mitochondrial and cytosolic compart-
ments, respectively (Fig. 2A). Fractionated compartments of
medium-heavy labeled control and heavy labeled IAV infected
cells were subsequently combined in a 1:1 ratio. In contrast,
all light-labeled cell fractions of one experiment were com-
bined and served as an internal standard. This standard was
spiked in 1:2 ratio into the mixed compartment fractions. This
allowed the generation of protein fractionation profiles by
LC-MS/MS and the identification of IAV-induced changes in
the subcellular localization of proteins (ratio heavy/light over
all compartments compared with ratio medium-heavy/light
over all compartments). In affinity purification (AP) experi-
ments, it was shown that the time point of sample mixing
might influence the recovery of interacting proteins. Transient
interaction partners might be lost when samples are already
combined prior AP (39). To avoid exchange of dynamically
regulated proteins within mixed cell lysates, we decided to
fractionate infected and control cells separately and to com-
bine respective cell fractions. Average ratios of three biolog-
ical replicates of A549 cells and two biological replicates of
each Calu-1 and NCI-H1299 cells were used to generate
10,152 protein profiles (supplemental Table S6), which were
analyzed by fuzzy c-means clustering (Fig. 2B) (26, 27). Pro-
files separated into eight clusters of similar size and a GO
term-enrichment analysis was performed to detect enriched
protein groups in each cluster (Fig. 2B). As expected, clusters
and GO terms reflected the cell fractionation approach, e.g. in
cluster 2 and 5 protein profiles peaked in the cytosolic frac-
tion, which was mirrored by the enriched GO terms “cytosol,”
“cytoplasm,” and “proteasome complex.”
Autophagosomal Targeting of Ribosomal Proteins by IAV
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FIG. 2. IAV-induced changes of subcellular localizations of host proteins. A, SILAC-work flow of cell fractionation analysis. SILAC-
labeled A549, Calu-1 and NCI-H1299 cells were IAV infected for 24 h (Arg10/Lys8) with a MOI of 2 or left untreated (Arg6/Lys4 and Arg0/Lys0).
All labels were separated into nuclear, mitochondrial, cytosolic and vesicular fractions. The light labeled fractions were combined and the
protein concentration of all fractions and all labels was determined. The separated fractions of untreated and infected cells were mixed in a
1:1 ratio and the same amount of the combined light fraction was spiked in as an internal standard. Samples were prepared for MS analysis
as outlined. B, Protein profiles of biological replicates were merged (A549, n 3; Calu-1, n 2; NCI-H1299, n 2), standardized and clustered
using the fuzzy c-means algorithm. Profiles separated into 8 clusters of similar size. Color scale represents cluster membership values.
Enriched GO terms and UniProt keywords are highlighted next to respective clusters (FDR0.01, BH corrected). V: vesicle; C: cytosol; M:
mitochondrion; N: nucleus. C, Relative abundance of the MHC class-I subunits B2M and HLA-A in the nuclear fraction. Shown are average
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We identified one complex that exhibited an altered sub-
cellular localization because of IAV infection independent of
the analyzed cell line. The human leukocyte antigen (HLA)-A
and 2-microglobulin (B2M) forming the major histocompati-
bility complex class I (MHC class I) were found enriched in
cluster 6 in IAV infected cells, whereas they localized to clus-
ter 1 in control cells (Fig. 2B). Cluster 6 was enriched in ER
proteins and in agreement, both proteins HLA-A and B2M
were found significantly enriched in the nuclear fraction of IAV
infected cells (Fig. 2C). MHC class I proteins shuttle through
ER and Golgi apparatus before they reach the plasma mem-
brane. They present peptides to cytotoxic T cells, are critical
for the elucidation of an adaptive immune response and are
induced by type I interferons (40).
Consistent with the observation that the majority of signif-
icantly altered proteins because of IAV infection were ob-
served in single cell lines (Fig. 1D), also changes in protein
localization appeared to be mainly cell line-specific. For ex-
ample, in Calu-1 cells IAV infection led to a shift from the 20S
core proteasome from cluster 8 to cluster 5; in NCI-H1299
cells integrin complexes shifted from cluster 1 to cluster 6
(supplemental Table S6). In IAV infected A549 cells, ribosomal
proteins were overrepresented in cluster 2. A detailed analysis
of respective fractionation profiles indicated that the 45 de-
tected subunits of the large ribosomal subunit appeared to be
more abundant in the vesicular fraction of IAV infected A549
cells (Fig. 2D), a phenotype which was not observed in the two
other cell lines. WB analysis of the fractionation profile of
ribosomal protein RPL4 confirmed a significant increase in the
vesicular fraction of IAV infected cells (Fig. 2E, p  0.01, n 
3). For the 29 detected subunits of the small ribosomal sub-
unit, a change in localization was less obvious (Fig. 2F). As IAV
was shown to interfere with intracellular vesicle trafficking in
A549 cells (18), we decided to analyze its impact on the
vesicular compartment in more detail.
IAV-induces Changes of the Autophagosomal Proteome—
IAV infection was shown to interfere with lysosomal vesicle
targeting and to lead to an accumulation of autophagosomes,
specialized double-membrane vesicles critical for protein
degradation by autophagy (for review see (17)). However, it is
still under debate whether IAV infection blocks maturation or
leads to an increased production of autophagosomes, which
both would ultimately lead to an accumulation of these vesicle
(18, 41). Therefore, we analyzed the consequences of IAV
infection on lysosomal targeting of autophagosomes in our
experimental system. We used A549 cells stably expressing
the autophagosomal marker protein MAP1LC3B (LC3-II)
fused to GFP. Upon IAV infection, we observed an accumu-
lation of autophagosomes by IF to a similar extent as by
blocking lysosomal acidification/degradation by concanamy-
cin A (conA, Fig. 3A). Next, we analyzed autophagy flux by WB
comparing the band intensities of the autophagy receptor
SQSTM1 and of LC3-II in the presence and absence of conA
and IAV, respectively (Fig. 3B–3C) (42). In agreement with a
block of autophagosomal-lysosomal fusion (18), we detected
a decreased autophagy flux in our experimental conditions.
Thus, IAV infection resulted in an autophagy block, an accu-
mulation of autophagosomes and accordingly in an expan-
sion of the vesicular compartment.
To study if IAV infection changed the composition of the
vesicular proteome and led to an autophagosomal targeting
of ribosomal proteins, we performed again a PCP-SILAC-
based approach (Fig. 4A, supplemental Tables S7–S8) (22,
43). Cells were lysed by dounce homogenization, the vesicular
fraction was enriched by differential centrifugation and sepa-
rated by gradient centrifugation. Six fractions were collected,
and proteins therein analyzed by WB and LC-MS/MS. Protein
gradient profiles of conA-treated cells, which leads to a block
of constitutive autophagy, were compared with IAV infected
cells. In agreement to published data, in both conditions
autophagosomes were fractionated as controlled by WB anal-
ysis of GFP-linked LC3-II (Fig. 4B) (18, 43). Corroborating the
finding that IAV localizes to autophagosomes (18), we identi-
fied all viral proteins as comigrating with the autophagosomal
marker proteins LC3 and GABARAPL (Fig. 4C). Protein pro-
files were clustered and the potential autophagosomal cluster
was identified by known marker proteins (LC3, GABARAPL,
SQSTM1; supplemental Fig. S4, n  2). In IAV infected cells,
autophagosomes appeared to be more heterogeneous, as
marker proteins spread over two related clusters. A GO term
enrichment analysis of potential autophagosomal proteins
was performed, clearly discriminating the two treatments
(Fig. 4D). Whereas in conA-treated cells autophagosomes
appeared to contain mostly lysosomal and endosomal pro-
teins, IAV infection led to an accumulation of ribosomal
proteins, translation elongation factors (EEF1A, B, D, G),
and proteins involved in viral infection. Thus, IAV infection
appeared to lead to a global change in the proteomic com-
position of autophagosomes.
IAV Induces Accumulation of Ribosomes Inside Autopha-
gosomes—As GO term enrichment analysis indicated a virus-
dependent, increased localization of ribosomal proteins within
values of A549, Calu-1 and NCI-H1299 cells. Error bars indicate standard deviation. *: p  0.05, t test. D, IAV-induced changes in the cellular
localization of the large ribosomal subunit. Gray lines represent the standardized SILAC profiles (heavy versus light and medium-heavy versus
light) of all detected ribosomal proteins of the large ribosomal subunit (RPL, n  45). Black lines illustrate the average profiles. E, WB analysis
of the fractionation profile of the protein RPL4. Black bars indicate densitometric quantification of the presented blot. Bar diagram shows
quantification of three biological replicates (**: p  0.01). Error bars represent standard deviation. F, IAV-induced changes in the cellular
localization of the small ribosomal subunit. Gray lines represent the standardized SILAC profiles (heavy versus light and medium-heavy versus
light) of all detected ribosomal proteins of the small ribosomal subunit (RPS, n  29). Black lines illustrate the average profiles.
Autophagosomal Targeting of Ribosomal Proteins by IAV
Molecular & Cellular Proteomics 17.10 1915
 by guest on N
ovem
ber 14, 2018
http://w
w
w
.m
cponline.org/
D
ow
nloaded from
 
autophagosomal clusters, we studied a potential ribosome-
autophagosome crosstalk in IAV infected cells. Indeed, in
contrast to conA-treated cells, all detected proteins of the
large (n  32) and small (n  20) ribosomal subunit closely
followed autophagosomal marker proteins in gradient centrif-
ugations of IAV infected cells (Fig. 5A, 5B). Comigration in
gradient centrifugations could mean both, association with or
uptake by autophagosomes. This question was addressed
biochemically using a proteinase K protection assay (44),
which enables the discrimination between truly (intra)organ-
ellar proteins and associated proteins not inside vesicles. For
this, protease treatments were performed in the absence and
presence of detergent (Fig. 5C). Whereas soluble GFP-LC3-I
was degraded by proteinase K in the presence and absence
of detergent, the autophagy receptor SQSTM1 and mem-
brane-bound GFP-LC3-II, both mainly localizing inside au-
tophagosomes, were protease resistant in the absence of
detergent. Under control conditions, a minor protease resist-
ant band of the ribosomal protein RPL4 was detected. How-
ever, this behaved like the observed GFP-LC3-I bands indi-
cating that under control conditions ribosomes might only
comigrate with autophagosomes, in agreement with earlier
studies (43). Under IAV infection, autophagosomes appeared
to be more fragile, as partial digestion of GFP-LC3-II and
SQSTM1 were observed in the absence of detergent (Fig. 5C).
Importantly, although autophagosomes appeared more frag-
ile, RPL4 was protease resistant in the absence of detergent,
leading to a significant increase of the ribosomal protein in-
side autophagosomes under IAV treatment (Fig. 5D).
To test if in addition to viral proteins and ribosomes, viral
mRNA could be a cargo of autophagosomes, RNA was iso-
lated from gradient fractions. Primers for mRNAs encoding
viral M1 and NS1 and for the human housekeeping genes
18S and HPRT1 were used to determine the mRNA content
of the vesicular gradient fractions by PCR (Fig. 5E). Whereas
it was not possible to detect mRNA of human housekeeping
genes (data not shown), viral mRNA showed a similar gra-
dient profile as viral proteins. Thus, in addition to ribosomes
and viral proteins, viral mRNA appeared to localize to
autophagosomes.
DISCUSSION
As IAV infects epithelial cells of the lung (45), we used the
human lung epithelial cancer-derived cell lines A549, Calu-1
and NCI-H1299 to study proteomic consequences of IAV
infection. We analyzed protein abundance changes as well as
IAV-induced changes in subcellular protein localization and
identified pleiotropic effects, shedding light on processes so
far not known to be regulated by IAV. Although we quantified
84.3% of the analyzed proteins in minimum two out of the
three cell lines, only 36.1% of the IAV-dependent significantly
regulated proteins were identified in minimum two cell lines.
Thus, it appears that the cell response to IAV infection is
highly cell-line dependent. In signal transduction studies an-
FIG. 3. IAV blocks functional autophagy. A549 GFP-LC3 cells were either left untreated, infected with IAV for 24 h (MOI  2), treated for
7 h with 2 nM concanamycin A (conA), or infected for 24 h and treated for the last 7 h with 2 nM conA. A, Immunofluorescence of untreated,
conA treated and IAV-infected A549 GFP-LC3 cells. The green dots represent autophagosomes, nuclear DAPI-staining is shown in blue. Scale
bar represents 10 m. B, Immunoblot analysis of indicated host proteins of untreated, conA-treated, IAV-infected and IAV-infected and
conA-treated A549 GFP-LC3 cells. GAPDH served as a loading control. C, Level of autophagic flux of untreated and infected cells. The
measured intensity of LC3-II was normalized to GAPDH and the relative autophagic flux was calculated by dividing LC3-II intensities of samples
with conA by respective intensities without conA. Data of two biological replicates are shown relative to ctrl experiments.
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alyzing MTOR regulation it was shown that observed re-
sponses might vary substantially depending on the analyzed
cell line (46). Also, in studies analyzing cell responses to IAV
infection substantial differences between cell lines were ob-
served. Madin darby canine kidney (MDCK) cells were shown
to support IAV growth, whereas rhesus monkey kidney LLC-
MK2 cells were substantially less efficient (47). More critically,
even different clones derived from one parental MDCK cell
culture were shown to differ in their capacity to support mul-
ticycle IAV replication (48). Also, gender may influence phe-
notypic observations: for IAV it was shown that the gender of
infected mice influenced the humoral immune response (49).
Whereas in our study all cell lines were derived from male
donors, NCI-H1299 and Calu-1 cells derived from different
metastatic sites, which might explain some of the observed
differences.
With respect to the crosstalk between IAV infection and
autophagy regulation it is still debated if IAV infection leads to
an induction (20, 21) or block of functional autophagy (18, 19).
Our results imply that observed differences might be because
of the distinct cell types that were used: mouse embryonic
fibroblasts (MEFs), MDCK cells and A549 cells, respectively. If
results from different laboratories should be compared, the
use of identical cell lines appears to be critical. In the current
manuscript, we could recapitulate that IAV infection leads to a
reduced autophagic flux in A549 cells.
We could show that IAV positively regulated the abundance
of proteins involved in the class I IFN response, corroborating
literature knowledge (50). Importantly, we also characterized
so far unknown, common and cell line-specific molecular
details. Of the 11 proteins identified as significantly changed
in all infected cell lines only B2M and the fucosyltransferase
FUT3 were linked to virus infections before (51, 52). Expres-
sion of B2M is increased upon IAV infection. Members of the
FUT3 family were shown to influence norovirus-cell recogni-
tion. If and how FUT3 may influence IAV binding to glycosy-
lated cell surface receptors is not known.
In single cell lines, we could show that the E2 enzyme
UBE2L6 (in A549) and the E3 ligase HERC5 (in A549 and
NCI-H1299) were up-regulated on protein level, potentially
being causative for the increased modification of viral NS1 by
the ubiquitin-like modifier ISG15 (up-regulated in A549 and
NCI-H1299 cells). ISG15 was shown to have antiviral effects
(35, 53). Upon IAV treatment of A549 cells, we also identified
FIG. 4. IAV localizes to autophagosomes and changes the autophagosomal proteome. A, PCP-SILAC workflow of isolation of
autophagosomes via density gradient centrifugation. SILAC-labeled cells were dounced and the vesicular fraction was applied on iodixanol
gradients for gradient centrifugation. Six fractions were collected and the light labeled fractions were mixed together and applied in a 1:1 ratio
as an internal standard to the collected fractions of the heavy label. The combined samples were separated by SDS-PAGE, in-gel digested by
trypsin, and analyzed by LC-MS/MS. B, Western blot analysis of the autophagosomal marker protein LC3-II. Black bars indicate densitometric
quantification. C, Gradient profiles of viral and autophagosomal marker proteins. The gray lines represent the gradient distribution profiles of
all detected viral proteins. LC3 and GABARAPL indicate the distribution of autophagosomes over the gradient. See supplemental Fig. S4 for
all generated protein profiles. D, GO term enrichment of the autophagosomal clusters (AC) of conA and IAV treated cells. Content of AC of IAV
and conA treated cells were analyzed with Perseus for enriched GO terms. A selection of enriched GO terms is shown and the number of
proteins assigned to each particular GO term is shown in percent (p  0.01, BH corrected, minimum number of proteins in each category for
enriched GO terms were 5).
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increased abundance of the transcription factors PARP9, 10,
12 and 14, which belong to the same family of macroPAMPs
(pathogen-associated molecular patterns) and are implicated
in immune activation. The expression of PARP9 was shown to
be induced by IFN, which is also triggered by IAV, and
expression of PARP9 in lymphoma cells was found to in-
crease the expression of several interferon-stimulated genes
(54). PARP14 is involved in the transcriptional activation of the
IL4 gene and may promote an inflammatory response. To our
knowledge, both PARP9 and 14 were so far not found to be
up-regulated by virus infection. PARP9 and the E3 ubiquitin-
protein ligase DTX3L, which was also identified as increased
in A549 cells, are located in a head-to-head orientation on
chromosome 3q21 and are regulated by an IFN-responsive
bidirectional promoter (55). DTX3L binds to PARP9 and reg-
ulates its subcellular localization, highlighting a coordinated,
IAV-dependent expression of PARP9 and DTX3L in A549
cells.
Next to changes in protein abundance, IAV also affected
the subcellular localization of host proteins. Whereas MS-
based proteomics approaches were used in the past to study
the effects of influenza virus on organellar proteomes, among
others nucleus, nucleolus, mitochondrion and cytosol (56–
58), a detailed analysis of the underlying dynamics was miss-
ing. To our knowledge, this is the first attempt to globally
analyze IAV-induced changes in cellular protein localization.
Most of the changes in cellular reorganization of protein com-
plexes seemed again to be cell line dependent, such as the
reduced nuclear abundance of the 20S core proteasome in
Calu-1 cells upon IAV infection (change from cluster 8 to 5). As
IAV was shown to interfere with vesicle trafficking and as the
physiological consequences of this are still under debate, we
decided to focus our analysis on the IAV induced changes of
the vesicular proteome (17).
Upon IAV infection, we identified an increased abundance
of ribosomal proteins in vesicular fractions of A549 cells.
Ribosomal proteins commonly localize to the nucleus for ri-
bosome biogenesis and to the cytosol where protein transla-
tion takes place. However, under stress conditions ribosomes
may be taken up by autophagosomes for lysosomal degra-
dation (59–61). As also IAV proteins were localized to au-
tophagosomes and as IAV infection was shown to interfere
with autophagosome trafficking (18), we analyzed autophagy
and autophagosomal protein content in IAV treated cells in
detail. In the chosen experimental system, IAV blocked
autophagosome maturation. Therefore, we compared au-
tophagosomes accumulated following IAV infection to
autophagosomes accumulated by conA treatment, repre-
senting autophagosomes under basal conditions (43). Auto-
phagosomes appeared to be more heterogeneous and fragile
under IAV treatment as indicated by gradient profiles of re-
spective marker proteins and decreased stability in protease
protection assays. This could be because of an IAV-depen-
dent redirection of autophagic membranes to the plasma mem-
brane and the site of IAV budding (19). By biochemical assays,
we showed that ribosomal proteins are inside autophago-
FIG. 5. IAV infections leads to localization of ribosomes and viral mRNA to autophagosomes. A–B, Gradient profiles of large (A) and
small (B) ribosomal and autophagosomal marker proteins. The gray lines represent the gradient distribution profiles of all detected ribosomal
proteins of the large (RPL, n  31) and small subunit (RPS, n  17) of the corresponding treatment. LC3 and GABARAPL indicate the
distribution of autophagosomes over the gradient. C, Proteinase K protection assay. A549 GFP-LC3 cells were either stimulated with conA for
7 h or infected with IAV for 24 h. After differential centrifugation, the vesicular fraction was used for the protease protection assay. Shown are
two biological replicates each. SQSTM1, RPL4 and LC3 were detected via WB. D, Quantification of data exemplified in (C). The RPL4 intensity
was quantified by densitometry relative to SQSTM1 and GFP-LC3-II (n  6; **: p  0.01). Error bars represent standard deviations. E, mRNA
content of autophagosomes. mRNA was purified from the combined vesicular gradient fractions 2 and 3, 4 and 5, 6 and 7, respectively.
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somes upon IAV treatment, and that viral mRNA appeared to
be taken up by autophagosomes as well. Interestingly, it was
reported that ribosome composition might vary dependent on
cell growth conditions (62–66). Whether it is conceivable that
IAV infection leads to an altered ribosome composition next to
an altered localization, this was not addressed in the current
study and will have to be tested by directly analyzing ribo-
somal proteomes, e.g. by affinity purification (AP)-MS and
size exclusion chromatography (SEC)-MS experiments ana-
lyzing ribosomal protein interactomes (67).
The altered ribosome localization together with the local-
ization of translation elongation factors and viral proteins in-
side autophagosomes (18) opens up the possibility that active
viral protein biosynthesis might happen inside autophago-
somes. Whether this is of physiological importance remains
elusive. Whereas it was reported by several laboratories that
autophagy incompetent cells produce less viral proteins, an
effect on viral titer was not found so far (18, 68). However, it
appears conceivable that autophagy initially served as viral
defense mechanism and subsequently was modified by vi-
ruses to promote viral replication as was shown e.g. in the
case of hepatitis C virus (for review see (69)). Interestingly, a
time-dependent effect of autophagy levels on IAV titer was
described (70). Our findings could highlight the cell biological
reasons for these phenotypic observations.
Taken together, by a comprehensive MS-based proteomics
approach we identified IAV-dependent changes in host cell
protein abundances as well as localizations. Whereas IAV
infection influenced common immunomodulatory pathways in
all analyzed cell lines, it also led to significant cell line-specific
responses. In A549 cells, we characterized the autophago-
some as a potential organelle in which viral protein translation
may take place. Whether this is susceptible for manipulation
and regulated in a time-dependent fashion influencing viral
titers remains to be studied.
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